In addition, we found that ETV4 has a predictive effect on the immunotherapy outcomes for melanoma and renal cell carcinoma, with high ETV4 expression indicating poorer responses to immunotherapy. The gene discussed is ETV4; the disease is hereditary clear cell renal cell carcinoma.